Pharmacokinetics and tissue distribution of zidovudine in rats following intravenous administration of zidovudine myristate loaded liposomes

Pharmazie

Volumn 60, Issue 11, 2005, Pages 840-843

  Jin, S X ^a   Bi, D Z ^a   Wang, J ^b   Wang, Y Z ^a   Hu, H G ^a   Deng, Yi Hui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Shanghai Center of Research and Development of New Drugs   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LIPOSOME; UNCLASSIFIED DRUG; ZIDOVUDINE; ZIDOVUDINE DERIVATIVE; ZIDOVUDINE MYRISTATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG TISSUE LEVEL; ENCAPSULATION; FEMALE; FREEZE DRYING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHUMAN; RAT; RETICULOENDOTHELIAL SYSTEM; TISSUE DISTRIBUTION;

ANIMALS; ANTI-HIV AGENTS; DISACCHARIDES; DRUG CARRIERS; FEMALE; HALF-LIFE; INJECTIONS, INTRAVENOUS; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYRISTIC ACID; PARTICLE SIZE; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, INFRARED; SUSPENSIONS; TISSUE DISTRIBUTION; ZIDOVUDINE;

EID: 28244472772     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Allen TM, Austin GA, Chonn A, Lin L, Lee KC (1991) Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Biochim Biophys Acta 1061: 56-64.
2. Aquaro S, Calio R, Balzarini J, Bellocchi MC, Garaci E, Perno CF (2002) Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. Antiviral Res 55: 209-225.
3. Dusserre N, Lessard C, Paquette N, Perron S, Poulin L, Tremblay M, Beauchamp D, Désormeaux A, Bergeron MG (1995) Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vivo anti-HIV-1 activity, tissue distribution and pharmacokinetics. AIDS 9: 833-841.
4. Gulati M, Grover M, Singh S, Singh M (1998) Lipophilic drug derivatives in liposomes. Int J Pharm 165: 129-168.
5. Kawaguchi T, Ishikawa K, Seki T, Juni K (1990) Ester prodrugs of zidovudine. J Pharm Sci 79: 531-533.
6. Löbenberg R, Araujo L, Von Briesen H, Rodgers E, Kreuter J (1998) Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats. J Control Rel 50: 21-30.
7. Parang K, Wiebe LI, Knaus EE (1998a) Synthesis, in vitro anti-human immunodeficiency virus structure-activity relationships and biological stability of 5′-O-myristoyl analogue derivatives of 3′-azido-2′, 3′-dideoxythymidine (AZT) as potential prodrugs. Antivir Chem Chemother 9: 311-323.
8. Parang K, Wiebe LI, Knaus EE (1998b) Pharmacokinetics and tissue distribution of (±)-3′-azido-2′,3′-dideoxy-5′-O- (2-bromomyristoyl) thymidine, a prodrug of 3′-azido-2′,3′- dideoxythymidine (AZT) in mice. J Pharm Pharmacol 50: 989-996.
9. Phillips NC, Skamene E, Tsoukas C (1991) Liposomal encapsulation of 3′-azido-3′-deoxythymidine (AZT) results in decreased bone marrow toxicity and enhanced activity against murine AIDS-induced immunosuppression. J Acquir Immune Defic Syndr 4: 959-966.
10. Phillips NC, Tsoukas C (1992) Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndrome. Blood 79: 1137-1143.
11. Sawchuk RJ, Yang Z (1999) Investigation distribution, transport and uptake of anti-HIV drugs to the central nervous system. Adv Drug Deliv Rev 39: 5-31.
12. Yoshie M, Hiroshi S, Wan JP, Kozo T (2001) Modified ethanol injection method for liposomes containing β-D-glucoside. J Liposome Res 11: 115-125.